Top Analyst Calls: Nvidia, Salesforce, ServiceNow, Abbott, Lockheed

As the third quarter gets underway, Wall Street analysts have issued a flurry of research calls on major stocks. Here are the most significant changes for Nvidia (NVDA), Salesforce (CRM), ServiceNow (NOW), Abbott Laboratories (ABT), and Lockheed Martin (LMT).

Nvidia (NVDA)

Bank of America raised its price target on Nvidia from $150 to $175, maintaining a "Buy" rating. The analyst cited strong growth expectations in AI, particularly rising demand for GPUs used in data centers.

Salesforce (CRM)

Goldman Sachs downgraded Salesforce from "Buy" to "Neutral" and cut its price target from $280 to $260. The analyst pointed to slowing revenue growth in the cloud solutions segment and increased competition from Microsoft.

ServiceNow (NOW)

Morgan Stanley raised its price target on ServiceNow from $800 to $850, with an "Overweight" rating. The analyst believes the company's digital workflow platform will benefit from accelerated digital transformation in enterprises.

Abbott Laboratories (ABT)

Deutsche Bank raised its price target on Abbott from $120 to $130, with a "Buy" rating. The upgrade is based on strong performance in medical diagnostics and diabetes monitoring devices.

Lockheed Martin (LMT)

Barclays lowered its price target on Lockheed Martin from $500 to $480, with an "Equal Weight" rating. The reduction comes amid concerns about potential pressure on the U.S. defense budget.

What It Means

These calls reflect divergent outlooks across sectors. While tech remains buoyed by AI, some firms face competitive headwinds. Healthcare appears more stable, while defense faces some uncertainty.